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Edited by Maurice MontalAbstract Inﬂammatory stimuli provide critical activation
signals for dendritic cells (DC). Signaling through the capsaicin
receptor TRPV1 is reported to initiate DC maturation and
migration. We attempted to characterize TRPV1 channels in
DC. Capsaicin or extracellular protons failed to elicit a change
in intracellular [Ca2+] or membrane current in DC. In contrast,
capsaicin evoked a sustained increase in [Ca2+] and large inwards
currents in sensory neurons and TRPV1-expressing HEK293
cells. TRPV1 expression was conﬁrmed by RT-PCR in sensory
neurons, but was undetectable in DC. Interestingly, and in
contrast to capsaicin, the inﬂammatory neuropeptide substance
P evoked Ca2+ transients in DC. Thus, our data do not support
the hypothesis that DC express TRPV1 channels. Rather, signal-
ing through TRPV1 in sensory nerves may modulate DC via neu-
rogenic actions.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Dendritic cells (DC) are the sentinels of the immune system.
After encountering inﬂammatory or ‘‘danger’’ stimuli, typically
in the form of microbes, inﬂammatory molecules or allergens,
DC mature and migrate to secondary lymphoid tissues. Mature
DC are potent stimulatory cells and can trigger the activation of
antigen-speciﬁc eﬀector and memory lymphocytes [1–3]. Identi-
ﬁcation of signaling pathways that regulate DC function is an
area of intense research; the ability to modulate these pathways
may have important therapeutic applications.
DC activation is signaled through diverse pathways that in-
clude the detection of microbes and their products through pat-
tern recognition receptors, such as Toll-like receptors (TLR) [4].Abbreviations: CGRP, calcitonin gene related peptide; DC, dendritic
cells; DRG, dorsal root ganglia; FITC, ﬂuorescein isothiocyanate; PE,
phyocoerythrin; TRPV1, transient receptor potential channel vanilloid
type 1; SP; substance P
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doi:10.1016/j.febslet.2005.08.023The release and subsequent recognition of inﬂammatory self
molecules also leads to potent DC maturation and migration.
Self-derived inﬂammatory stimuli include purinergic nucleo-
tides and uric acid released by dying cells, proinﬂammatory
cytokines from parenchymal cells, and neuropeptides secreted
by sensory neurons [1,5–8]. Recently, it was reported that
mouse DC express the capsaicin receptor transient receptor po-
tential channel vanilloid type 1 (TRPV1) [9]. TRPV1 is an ion
channel and a polymodal receptor for various inﬂammatory
stimuli including protons, heat and lipid metabolites [10,11].
TRPV1 is expressed primarily in nociceptive sensory nerves
andmay be essential for transducing inﬂammatory hyperalgesia
[12,13]. In the skin, TRPV1-immunoreactivity is also found in
keratinocytes [14,15], and to a lesser extent in mast cells [16]
but has not been reported for other immune cells [16]. Thus,
expression of TRPV1 by DC would imbue these antigen-
presenting cells with an especially sensitive mechanism for inte-
grating inﬂammatory stimuli and signaling their maturation.
In this study, we attempted to characterize the properties of
TRPV1 in mouse bone marrow-derived DC (BMDC). We re-
port that BMDC fail to respond to capsaicin using Ca2+ imag-
ing and electrophysiological techniques. Moreover, we ﬁnd no
detectable expression of TRPV1 mRNA by in vitro generated
BMDC, or DC isolated from bulk splenocytes. Thus, we con-
clude that mouse DC do not express TRPV1. In contrast to
capsaicin, the neuropeptide substance P elicited a rise in
[Ca2+] in DC. Therefore the reported eﬀects of capsaicin on
dermal DC migration are likely indirect responses due to the
activation of sensory nerves and keratinocytes and the ensuing
cutaneous inﬂammation.2. Materials and methods
2.1. Culture and puriﬁcation of mouse DC
DC were cultured from bone marrow (BM) cells isolated from the
femurs and tibias of normal C57B1/6 mice (7–12 weeks old) using
GM-CSF and IL-4 (4 ng/ml and 1000 IU/ml, respectively) for 4–5
days as previously described [17]. In some experiments we cultured
DC using GM-CSF (8 ng/ml) alone for 6–8 days per the methods
of Lutz et al. [18]. Bone marrow-derived DC were activated by
the addition of LPS (100 ng/ml; L2654 Sigma, St. Louis, MO)
during the last 18 h of culture. DC were expanded in vivo by
administering Flt3 ligand (15 lg/10 d/ip). Spleen cells were incubated
overnight (18 h) with GM-CSF (4 ng/ml) to allow spontaneous mat-
uration of DC.
DC were enriched from bone marrow cultures or spleen cells by den-
sity centrifugation. Brieﬂy, 2 ml of 140 mg/ml histodenz (Sigma,
D2158) was overlayed with 8 ml of cell suspension (5 · 106 cells/ml)blished by Elsevier B.V. All rights reserved.
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rated from the interface and labeled with anti-CD11c and anti-CD86
conjugated to ﬂuorescein isothiocyanate (FITC) and phycoerythrin
(PE), respectively (BD Biosciences, San Jose, CA). CD11c+ CD86
(immature) and CD11c+ CD86+ (mature) cells with high forward-
and side scatter proﬁles were separated and puriﬁed >95% purity using
a BD FACs Vantage SE cell sorter (BD Biosciences).
2.2. Neuronal and HEK293 cell culture
Dorsal root and nodose ganglia were obtained from adult mice
(C57Bl/6) killed by CO2 narcosis/decapitation. Ganglia were digested
with collagenase, and cultured in Neurobasal/B-27 medium (Invitro-
gen, Carlsbad, CA) on poly-D-lysine-coated glass coverslips. Neurons
were used within 24–36 h of culture. HEK293 cells were transfected
with rat TRPV1 (gift of David Julius, University of California San
Francisco) and GFP cDNA using Lipofectamine Transfection Re-
agent (Invitrogen) according to the manufacturers instructions and
used 24–48 h after transfection.
2.3. Ca2+-imaging and electrophysiology
DC and sensory neurons were loaded with 1 lMFluo 4-AM (Molec-
ular Probes, Eugene, OR) for 20 min and washed for a further 10–
20 min prior to recording. The dye was excited at 480 ± 15 nm. Emit-
ted ﬂuorescence was ﬁltered with a 535 ± 20 nm bandpass ﬁlter,
captured by a SPOT RT digital camera (Diagnostic Instruments, Ster-
ling heights, MI) and read into a computer. Analysis was performed
oﬄine using Simple PCI software (Compix Inc. PA). Drugs were ap-
plied via a gravity-fed micropipette (100 lm diameter) positioned
at a distance of 0.5 mm from the cell of interest, or via a pressure-
ejection system.
Whole-cell patch clamp recordings were performed using an EPC8
ampliﬁer (HEKA). The bath solution contained (in mM): 140 NaCl,
4 KCl, 1 MgCl2, 1 EGTA, 10 HEPES, 10 glucose, and pH 7.3 with
no added Ca2+. The standard pipette solution contained (in mM):
130 K-Gluconate, 10 NaCl, 1 MgCl2, 5 EGTA, 10 HEPES, 2 MgATP,
0.3 Na2GTP, and pH 7.3. The current signal was low-pass ﬁltered at 1–
3 kHz and sampled at 4 kHz. Currents were further ﬁltered for display
purposes.
2.4. RT-PCR
Total cellular RNA was extracted using TRIzol (Invitrogen) accord-
ing to the manufacturers instructions. First strand cDNA synthesis
was performed using Advantage RT-for-PCR (BD Biosciences) with
the supplied oligo (dT)18 primer. Twenty-ﬁve ng of cDNA was used
for each subsequent 25 ll PCR. Comparable quantities of cDNA wereFig. 1. Capsaicin does not alter intracellular [Ca2+] in mouse DC. (A) Left,
control conditions, and in the presence of capsaicin (1 lM) and extracellular A
cells. (B) Left, images of a Fluo-4 loaded DRG neuron before and after treatm
time for 8 neurons. Scale bars represent 20 lm.ensured by amplifying a 407 bp segment of GAPDH (forward 5 0-CCA
AGT ATG ATG ACA TCA AGA AGG-3 0; reverse 5 0-TAT TCA
AGA GAG TAG GGA GGA GGG CTC-3 0) using Taq DNA poly-
merase (Eppendorf; Hamburg, Germany). A 346 bp fragment of
TRPV1 was ampliﬁed as described by Zhang et al. [19] (TRPV1 for-
ward 5 0-TCG TCT ACC TCG TGT TCT TGT TTG-3 0 and TRPV1
reverse 5 0-CCA GAT GTT CTT GCT CTC TTG TGC-3 0). In addi-
tion, we assessed the ampliﬁcation of TRPV1 as described by Basu
and Srivastava [9] (1561 5 0-CCTGCTCAACATGCTCATTG-30 and
1562 5 0-TCCTCATGCACTTCAGGAAA-3 0). RT-PCR products
were separated by agarose gel electrophoresis and visualized with
SYBR Safe (Molecular Probes) ﬂuorescence. PCR products were se-
quenced by the DNA Sequencing facility (Robarts Research Institute,
London, Ontario).3. Results
3.1. Capsaicin and protons do not increase intracellular [Ca2+]
in mouse DC
To test for functional TRPV1 responses we performed Ca2+
imaging experiments in Fluo-4 loaded BMDC. Fig. 1A shows
that capsaicin (1 lM) produced no change in intracellular
[Ca2+] and this was conﬁrmed in more that 250 cells. Further,
we observed no change in [Ca2+] over a range of supramaximal
capsaicin concentrations (1–100 lM, n = 36). Most of these
DC responded to extracellular ATP (100 lM) which is known
to mobilize Ca2+ via P2Y receptors [17,20] demonstrating that
these cells were viable and capable of generating large Ca2+ re-
sponses. Similarly, extracellular protons (pH 5.5) another well
characterized activation signal for TRPV1, also failed to evoke
any Ca2+ responses in all DC tested (n = 12). In contrast, cap-
saicin (Fig. 1B) and protons produced a marked and sustained
Ca2+ elevation in cultured sensory neurons. These responses
occurred in 50% of small neurons (n > 200) consistent with
the expression of TRPV1 in these cells.3.2. Capsaicin fails to evoke membrane currents in mouse DC
The absence of capsaicin-evoked Ca2+ responses in DC
could potentially reﬂect very low TRPV1 expression or thetransmitted-light and ﬂuorescence images of Fluo-4 loaded DC under
TP (100 lM). Right, normalized Fluo-4 ﬂuorescence versus time for 35
ent with 1 lM capsaicin. Right, normalized Fluo-4 ﬂuorescence versus
Fig. 2. Capsaicin fails to evoke membrane currents in mouse DC.
(A) Current trace from a voltage-clamped DC (Membrane capaci-
tance, 17 pF; holding potential, 60 mV) in response to 1 lM
capsaicin and 100 lM ATP. (B and C) Current traces from a nodose
ganglion neuron and TRPV1-expressing HEK293 cell in response to
1 lM capsaicin (holding potential, 50 mV).
Fig. 3. Mouse DC do not express transcripts for TRPV1. (A) Mouse
DC were puriﬁed from bone marrow cultures or bulk splenocytes by
cell sorting for CD11c+ cells. Based on the expression of the
costimulatory molecule CD86, DC were separated into immature
(CD86), or mature (CD86+) fractions. (B) Detection of TRPV1
mRNA expression in immature, mature or LPS activated DC from
bone marrow cultures, or spleen. Dorsal root ganglia (DRG) were
used as the positive control for TRPV1 expression. Ampliﬁcation of
GAPDH was used as the housekeeping control.
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test further for TRPV1 functionality we studied the eﬀects of
capsaicin in voltage clamped BMDC. Fig. 2A shows that cap-
saicin (1 lM) failed to produce any inward current in these
cells (n = 10). Some of these DC responded to extracellular
ATP with transient inward currents consistent with activation
of P2X channels (Fig. 2A) [20]. In contrast, capsaicin (1 lM)
evoked large currents in both sensory neurons and TRPV1-
expressing HEK293 cells (Fig. 2B and C).
3.3. Mouse DC do not express mRNA for TRPV1
To examine the expression of mRNA for TRPV1, DC were
prepared in vitro from mouse bone marrow or isolated directly
from mouse spleen cells. DC were puriﬁed to >95% homogene-
ity for both immature (CD11c+ CD86) and mature (CD11c+
CD86+) DC by cell sorting (Fig. 3A). As TRPV1 has been
linked to DC maturation, BMDC were also activated with
LPS prior to puriﬁcation. RT-PCR readily ampliﬁed a 346bp
fragment of the TRPV1 gene transcript in mouse sensory neu-
rons (Fig. 3B). In contrast, TRPV1 gene transcripts were unde-
tectable in either cultured BMDC, or mouse spleen DC.
Moreover, DC maturation or activation did not induce the
expression of TRPV1 transcripts.
3.4. RT-PCR ampliﬁcation of TRPV1
The lack of TRPV1 mRNA and functional responses de-
scribed here is in stark contrast with the previous report by
Basu and Srivastava [9]. In particular, we were confounded
by their detection of the TRPV1 gene product in BMDC. As
positive or RT-negative controls were not reported for these
experiments, and a diﬀerent primer set was used for ampliﬁca-
tion of TRPV1 cDNA, we examined the primer binding sites
and determined the predicted PCR products. As shown in
Fig. 4A, the primer set 1561 + 1562 reported by Basu and Sri-
vastava [9] binds genomic DNA with a predicted product of
983 bp. Interestingly, this same primer set binds TRPV1cDNA, however, the predicted product is 133 bp (Fig. 4B)
which is not consistent with the reported 984 bp product.
Our predictions were accurately conﬁrmed by ampliﬁcation
of genomic and cDNA samples using 1561 + 1562 (Fig. 4D).
In contrast, a 346 bp fragment was predicted based on align-
ment of our TRPV1 primers with the TRPV1 cDNA
(Fig. 4C), and was empirically conﬁrmed as shown in
Fig. 4D. The identity of all PCR products was conﬁrmed by
DNA sequencing. Notably, TRPV1 F+R primers do not am-
plify a product from DNA. Thus, the 984 bp product reported
by Basu (2005) as the TRPV1 gene transcript in BMDC is, al-
most certainly, a genomic contamination. Moreover, their fail-
ure to detect the 133 bp PCR product indicates that their DC
samples do not express TRPV1 mRNA; a result which is con-
sistent with the data reported herein.
3.5. Substance P evokes Ca2+ transients in BMDC
Since our data revealed no evidence for TRPV1 expression
in DC we tested for alternative mechanisms by which capsaicin
might regulate DC function. Capsaicin-sensitive neurons are
well known to release neuropeptides, including substance P,
which can mediate inﬂammation and leukocyte migration
[6,7]. We therefore tested whether DC were sensitive to
Fig. 4. Analysis of primer binding to TRPV1 genomic and cDNA
sequences. Schematic representation of primer set 1561 + 1562 binding
to TRPV1 (A) genomic and (B) cDNA sequences. (C) TRPV1 F + R
primer binding to TRPV1 cDNA. The predicted PCR products are
represented by the dotted line. (D) PCR ampliﬁcation of genomic
DNA and DRG cDNA.
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marked increase in intracellular [Ca2+] and this occurred in
30 of 60 cells tested. This is the ﬁrst report of substance P-in-
duced Ca2+ transients in DC, and is consistent with expression
of neurokinin, NK1 receptors (coupled to phospholipase C),
previously documented in both murine and human DC [21].
Thus, capsaicin may indirectly regulate DC function in vivoFig. 5. Substance P evokes a rise in intracellular [Ca2+] in DC. Left, transmi
conditions, and after application of 50 nM substance P (SP). Scale bar repre
cells.by triggering the release of neuropeptides such as substance
P from sensory nerve endings.4. Discussion
DC are multi-potent regulators of the immune system. They
are ubiquitously distributed throughout the body as immature
cells, specialized for the uptake and transport of self and for-
eign antigens to lymphoid tissues. Concomitant with migra-
tion, DC mature and become powerful initiators of adaptive
immune responses [1–3]. Our understanding of DC functional
ontogeny was challenged by Matzinger (1994) [22], who pro-
posed that their maturation is triggered by broadly recognized
inﬂammatory stimuli. The ‘‘danger’’ model dictates that DC
activation is signaled not only by microbes and their products,
but also by cellular stress or damage [22]. In this context, the
identiﬁcation of receptors and/or signaling pathways in DC
that respond to inﬂammatory stimuli becomes very signiﬁcant.
One such receptor is the ion channel TRPV1, a polymodal
detector of noxious stimuli [10,11]. TRPV1 was recently re-
ported to be expressed in mouse DC and to signal maturation
and enhanced migration of cutaneous DC [9]. The high Ca2+
permeability of TRPV1 [10] could be relevant to DC function
since intracellular Ca2+ is known to promote DC maturation
[17,23]. However, our data do not support the hypothesis that
DC express TRPV1 channels. DC were unresponsive to capsa-
icin, the deﬁnitive TRPV1 agonist, and to extracellular protons
(pH 5.5) in both Ca2+ imaging and electrophysiological assays.
Moreover, we could not detect mRNA for TRPV1 in DC
either cultured from bone marrow, or isolated from mouse
splenocytes. Importantly, our analyses were performed on
DC obtained from two well characterized sources and at diﬀer-
ent stages of maturation. Moreover, using sensory neurons we
were able to demonstrate robust responses to capsaicin in
functional assays and strong expression of the TRPV1 gene
product. Our results are consistent with an earlier study which
found no TRPV1 expression in Langerhans cells, the resident
DC of the epidermis [16].
Our data contradict the conclusions of a recent study by
Basu and Srivastava [9]. Several results in that study however,
indicate that the authors were not measuring bone ﬁde TRPV1
expression or function. First, their RT-PCR analysis yielded a
solitary DNA product of 984 bp, which they erroneously inter-
preted as TRPV1 mRNA expression (see Fig. 4A and D).
Importantly, they did not detect the 133 bp product that cor-
responds with ampliﬁcation of TRPV1 cDNA (Fig. 4B and
D). Thus, contrary to their conclusions the data of Basu andtted-light and ﬂuorescence images of Fluo-4 loaded DC under control
sents 20 lm. Right, normalized Fluo-4 ﬂuorescence versus time for 14
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samples and in fact, agree with the data we report here.
Second, capsaicin was reported to alter DC maturation only
at concentrations in the range 25–100 lM. These concentra-
tions are all super-saturating, and 100–1000-fold greater than
those needed to activate TRPV1 (the EC50 for capsaicin-in-
duced Ca2+ entry in TRPV1-expressing cells is 35–100 nM
[24]). At such high concentrations capsaicin has a myriad of
non-speciﬁc actions unrelated to TRPV1 that could inﬂuence
DC function [10]. Our results indicate that even 100 lM cap-
saicin fails to elicit any Ca2+ rise in DC indicative of TRPV1
activity. Thus, any biological eﬀects of treatment with these
high concentrations of capsaicin are almost certainly indepen-
dent of TRPV1.
Third, the authors concluded that enhanced migration of
DC in response to intradermal injection of capsaicin reﬂects
a direct eﬀect on cutaneous DC, because this was absent in
mice lacking TRPV1. An alternative and more likely explana-
tion is that DC migration was promoted by the well-described,
broad inﬂammatory eﬀects of capsaicin which are completely
void in TRPV1-null animals. Indeed, Ca2+ entry through
TRPV1 channels expressed in peripheral nerve terminals
evokes the release of the inﬂammatory neuropeptides sub-
stance P and calcitonin gene related peptide (CGRP) [10,11].
Of particular relevance to the skin immune system, the activa-
tion of TRPV1 in keratinocytes may amplify cutaneous inﬂam-
mation [14,15]. Epidermal DC express receptors for substance
P and CGRP and their function is known to be modiﬁed by
both neuropeptides [6,7,21]. This alternative hypothesis is well
supported by our data indicating a marked Ca2+ increase in
DC following substance P application. Thus, in TRPV1-null
animals the absence of the TRPV1 channel in nerve endings
and keratinocytes capable of triggering neurogenic inﬂamma-
tory cascades in the skin, would preclude leukocyte migration
in response to capsaicin.
In summary, administration of capsaicin into the mouse skin
is likely to signal through TRPV1 expressed by sensory nerves
and keratinocytes that trigger a broad inﬂammatory cascade.
The release of substance P and CGRP from neurons, together
with proinﬂammatory cytokines such as TNFa and IL-1b,
undoubtedly leads to the enhanced migration of cutaneous
DC and the accumulation of activated DC in draining lymph
nodes. DC do not express TRPV1 and hence, respond indi-
rectly to the administration of capsaicin, in vivo.
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